Hepatitis C: Current and future treatment

被引：0

作者：

Keeffe, EB ^{[1
]}

机构：

[1] Stanford Univ, Med Ctr, Liver Transplant Program, Stanford, CA 94305 USA

来源：

INFECTIONS IN MEDICINE | 2000年 / 17卷 / 09期

关键词：

hepatitis C; interferon; ribavirin; alfacon-1;

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Interferon alfa-2b, 3 million units tiw, plus ribavirin, 1000 to 1200 mg daily for 6 to 12 months, has shown an improvement of 2-fold or more for all measures of efficacy when compared with interferon monotherapy. Ln the next year, treatment of chronic hepatitis C will involve pegylated interferons, either alone or in combination with ribavirin. Therapy in 3 to 5 years will likely be multidrug combinations, including inhibitors of the hepatitis C virus (HCV) protease, helicase, or polymerase, with the aim of reducing serum levels or eradicating HCV RNA.

引用

页码：603 / +

页数：6

共 36 条

[1] Treatment strategies for chronic hepatitis C: Update since the 1997 National Institutes of Health Consensus Development Conference [J].

Ahmed, A ;

Keeffe, EB .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 :S12-S18

[2] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].

Alter, MJ ;

Kruszon-Moran, D ;

Nainan, OV ;

McQuillan, GM ;

Gao, FX ;

Moyer, LA ;

Kaslow, RA ;

Margolis, HS .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562

[3]

[Anonymous], 1999, J Hepatol, V30, P956

[4]

[Anonymous], 1997, HEPATOLOGY, V26, pS2

[5]

[Anonymous], VIRAL HEPAT REV

[6] Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy [J].

Bonkovsky, HL ;

Woolley, JM .

HEPATOLOGY, 1999, 29 (01) :264-270

[7] Chronic hepatitis C:: Interferon retreatment of relapsers.: A meta-analysis of individual patient data [J].

Cammà, C ;

Giunta, M ;

Chemello, L ;

Alberti, A ;

Toyoda, H ;

Trepo, C ;

Marcellin, P ;

Zahm, F ;

Schalm, S ;

Craxi, A .

HEPATOLOGY, 1999, 30 (03) :801-807

[8] Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials [J].

Carithers, RL ;

Emerson, SS .

HEPATOLOGY, 1997, 26 (03) :S83-S88

[9] High-tech industry marketing: The elements of a sophisticated global strategy [J].

Davies, W ;

Brush, KE .

INDUSTRIAL MARKETING MANAGEMENT, 1997, 26 (01) :1-13

[10]

Davis GL, 1999, SEMIN LIVER DIS, V19, P103

← 1 2 3 4 →